| |
| |
|
| Insider
Information: |
Atlas Venture Opportunity Fund I, L.p. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
15,854,037 |
|
|
Indirect Shares
|
3,419,644 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
19,273,681 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
10% Owner |
2019-06-24 |
0 |
2020-02-07 |
404,079 |
Premium* |
|
|
Kymera Therapeutics, Inc. |
KYMR |
10% Owner |
2020-08-25 |
7,948,982 |
2020-08-25 |
1,112,686 |
Premium* |
|
|
Generation Bio Co. |
GBIO |
10% Owner |
2021-09-17 |
7,111,939 |
2021-09-17 |
1,166,937 |
Premium* |
|
|
Xilio Therapeutics, Inc. |
XLO |
10% Owner |
2021-10-26 |
0 |
2021-10-26 |
735,942 |
Premium* |
|
|
Day One Biopharmaceuticals, Inc. |
DAWN |
10% Owner |
2022-07-01 |
793,116 |
2022-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DAWN |
Day One Biopharmaceutical... |
10% Owner |
– – • |
2022-07-01 |
4 |
AS |
$0.00 |
$0 |
D/D |
(198,280) |
793,116 |
0 |
- |
|
| XLO |
Xilio Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-26 |
4 |
B |
$16.00 |
$3,000,000 |
I/I |
187,500 |
735,942 |
1.5 |
- |
|
| XLO |
Xilio Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-26 |
4 |
A |
$0.00 |
$0 |
I/I |
2,545,529 |
548,442 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2021-09-17 |
4 |
AS |
$0.00 |
$0 |
I/I |
(100,000) |
1,166,937 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2021-09-17 |
4 |
AS |
$0.00 |
$0 |
D/D |
(1,000,000) |
7,111,939 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2021-06-16 |
4 |
AS |
$0.00 |
$0 |
I/I |
(100,000) |
1,266,937 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2021-06-16 |
4 |
AS |
$0.00 |
$0 |
D/D |
(1,000,000) |
8,111,939 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2020-12-15 |
4 |
AS |
$0.00 |
$0 |
I/I |
(1,151,882) |
11,478,876 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
10% Owner |
– – • |
2020-08-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,112,686 |
1,112,686 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
10% Owner |
– – • |
2020-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,196,584 |
7,948,982 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
10% Owner |
– – • |
2020-08-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
752,398 |
|
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2020-02-07 |
4 |
AS |
$0.00 |
$0 |
I/I |
(50,510) |
404,079 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-12-17 |
4 |
AS |
$0.00 |
$0 |
I/I |
(570,974) |
454,589 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-06-24 |
4 |
B |
$16.00 |
$4,320,000 |
I/I |
270,000 |
505,099 |
1.5 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-06-24 |
4 |
A |
$0.00 |
$0 |
I/I |
3,704,858 |
235,099 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
